FDA grants approval for neurostimulation device to treat epilepsy
The U.S. Food and Drug Administration has granted premarket approval for the NeuroPace® RNS® System to treat medically refractory epilepsy. The RNS System is a novel, implantable therapeutic device that delivers responsive neurostimulation, an advanced technology designed to detect abnormal electrical activity in the brain and respond by delivering imperceptible levels of electrical stimulation to [...]
Source: Neurobot - Category: Neurologists Authors: Dimitrios A. Adamos Tags: Stories Brain Interfaces Brain Research Deep Brain Stimulation Source Type: blogs
More News: Brain | Deep Brain Stimulation | Epilepsy | Food and Drug Administration (FDA) | Grants | Neurologists | Neurology